JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
Clinical trial NCT04780321 · COMPLETED
Trial details
- NCT number
- NCT04780321
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2021-08-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.